The Future of Tumor Treating Fields

I know you're one of the few docs I've run into who has an experience with this tumor treating fields and when we were talking at ASCA we were mentioning the fact that we were looking forward to seeing the big lung paper in tumor treating fields. So speaking of anti-microtubulets so you know the antibiotic drug conjugates our payloads until just recently have all been anti- microtubulets. We learned that from paklotaxel one of the best regiments we have right or agents the disruption of the tumor-trained field was basically opposing arrays. It's really interesting now utilizing an array where you put on your skin and your care in a backpack for